ALTIERI-1 Accelerator based BNCT activities in Europe.  Abstract
|
Tuesday
|
ALTIERI-2: Boron determination and imaging. Abstract
|
Wednesday
|
ASANO-1: Introduction of the world first commercially approved drug for BNCT. Abstract.
|
Wednesday
|
BALCERZYK-1: Quantification of boron compound concentration for BNCT in preclinical Positron Emission Tomography.
Abstract.
| Wednesday
|
BEDOGNI-1: Single moderator directional spectrometer for inline monitoring of epithermal neutron beams in BNCT facilities. Abstract
| Monday
|
BARTH-1: A realistic appraisal of Boron Neutron Capture Therapy as a cancer treatment modality.
Abstract
| Thursday
|
BOGGIO-1: In vivo dosimetry for BNCT treatments in Argentine trials. Abstract
| Wednesday
|
BORTOLUSSI-1: The dosimetry for in-vitro BNCT radiobiological studies. Abstract
| Wednesday
|
BUSSER-1: In situ visualization of Boron element in biological tissues: latest advances with LIBS imaging. Abstract
| Wednesday
|
CHANG-1: Dose Calculation Algorithm for Neutron Capture Therapy with Pre-Calculated TEGMA. Abstract.
|
Thursday
|
CHEMNITZ-1: Spectral properties of neutron beams available at FRM II for use in BNCT.
Abstract.
| Monday
|
CHEN-1: Design of a BNCT treatment planning system and its considerations - The development of NeuboronPlan. Abstract
| Thursday
|
CHENEVIER-1: BNCT as a global and interdisciplinary research thematic relying on large scale consortiums: the example of RENOVATE.
Abstract
| Wednesday
|
DAGROSA-1: Radiobiological studies of BNCT to thyroid carcinoma. Abstract.
| Wednesday
|
GENG-1: Assessment of secondary cancer risks for boron neutron capture therapy. Abstract.
| Wednesday
|
GENINATTI CRICHA-1: Quantification of Boron distribution by magnetic resonance imaging (MRI). Abstract
| Wednesday
|
GONZALEZ-1: State of the art and applications of radiobiological figures of merit in BNCT. Abstract
| Wednesday, Thursday
|
GRYZINSKI-1: Overview of the Polish activity for BNCT.
Abstract.
| Monday
|
HATAZAWA-1: Study of 4-borono-2-[18F]-fluoro-phenylalanine PET to estimate 10B concentration in tumors and normal organs in Boron Neutron Capture Therapy. Abstract.
| Wednesday
|
HEY-HAWKINS-1: Development of Tumour-selective Agents for Boron Neutron Capture Therapy (BNCT). Abstract.
| Wednesday
|
HIROSE-1: BNCT With an Accelerator-Based System and Borofalan(10B) for Recurrent or Locally Advanced Head and Neck Cancer (JHN002): An Open-Label Phase II Trial. Abstract.
| Thursday
|
HU-1: Development of a collimator built-in type dose distribution shifter for boron neutron capture therapy to superficial tumour. Abstract.
| Monday
|
IGAWA-1: Evaluation system of BNCT – in vitro and in vivo. Abstract.
| Wednesday
|
KASESAZ-1: BNCT at Tehran Research Reactor.Abstract.
| Tuesday
|
KALOT-1: Aza-BODIPY: a new vector for enhanced theranostic Boron Neutron Capture Therapy applications. Abstract
| Wednesday
|
KIYANAGI-1: Neutron sources for accelerator-based BNCT facilities. Abstract.
| Tuesday
|
KOIVUNORO-1: Treatment planning and dose calculation in Boron Neutron Capture Therapy. Abstract
| Thursday
|
KOIVUNORO -2: Out-of-field leakage in Boron Neutron Capture Therapy. Abstract.
| Monday
|
KONDO-1: Radiation Biology on BNCT - what we have known and don't know. Abstract.
| Wednesday
|
KREINER-1: Development of Accelerator Technology for BNCT in Argentina. Abstract.
| Tuesday
|
KUMADA-1: Beam Design Considerations for BNCT device
|
Monday
|
KUSUMOTO-1: Application of a novel concept DABBLE to biological effectiveness. Abstract.
| Wednesday
|
LEE-1: Neutron Beam and Radiation Protection Considerations for Boron Neutron Capture Therapy Using a Tandem Accelerator. Abstract.
| Tuesday
|
LI-1: Epithermal Neutron Beam Design based on MNSR for BNCT. Abstract.
| Monday
|
LIPENGOLTS-1: Boron clusters as promising boron carriers for BNCT. Abstract.
| Wednesday
|
LIU-1: Design considerations and recommendations of a BNCT beam shaping assembly.Abstract.
| Monday
|
LIU-2: Design considerations and recommendations of a BNCT on-line monitoring system- The development of BNCT on-line beam monitoring systems in the Xiamen.Abstract.
| Monday
|
LIU-3: Recommendations of characterizing and commissioning a clinical BNCT neutron beam. Abstract.
| Monday
|
MASUTANI-1: For the preclinical investigation of biological effectiveness of accelerator-based BNCT system. Abstract.
| Wednesday
|
MAURI-1: Clinical trial investigations on BNCT by molecular and network medicine. Abstract.
| Thursday
|
MITEV-1: The BNCT Development Project at the Institute for Nuclear Research and Nuclear Energy of the Bulgarian Academy of Sciences. Abstract.
| Tuesday
|
MIYATAKE-1: Accelerator-based BNCT in rescue treatment of patients with recurrent GBM: a multicenter phase II study. Abstract.
| Thursday
|
MIYATAKE-2: A phase II clinical trial using accelerator-based BNCT system for refractory recurrent high-grade meningioma. Abstract.
| Thursday
|
MONTI-1: Thermal and epithermal neutron fields from an electron medical-type LINAC for BNCT studies and detector test. Abstract.
| Monday
|
MONTI HUGHES-1: Optimizing BNCT for Different Pathologies: Translational In Vivo Studies Searching to Bridge The Gap Between Research and Clinical Application. Abstract.
| Wednesday
|
MURATA-1: Design of p-liquid Li Reaction Based ABNS for BNCT in Osaka University. Abstract.
| Tuesday
|
MURATA-2: Design of SPECT System for BNCT with GAGG Scintillator in Osaka University.
Abstract.
| Wednesday
|
NAKA-1: Synthesis of 4-borono-2-[18F]fluoro-L-phenylalanine (FBPA) by employing [18O]O2-use [18F]F2 production system and [18F]CH3COOF as a labeling agent.
Abstract.
| Wednesday
|
NAKAMURA-1: Boron Delivery Agents for BNCT: Current Status and Future Prospects. Abstract.
| Wednesday
|
NAKAMURA-2: Treatment facility design for an accelerator-based BNCT system in National Cancer Center Hospital. Abstract.
| Tuesday
|
NIEVAS-1: BNCT in Argentina: New contributions in analytical chemistry. Abstract.
| Wednesday
|
ONO-1: Organization, Operation and Management of a BNCT Treatment Facility and Regulatory Aspects. Abstract.
| Tuesday
|
PAN-1: Feasibility Study of the First Boron Neutron Capture Therapy Centre in Canada Using Prototype Compact Accelerator-based Neutron Source. Abstract.
| Tuesday
|
PORRA-1: Treatment Facility Design: Accelerator based Boron Neutron Capture Facility at Helsinki University Hospital. Abstract.
| Tuesday
|
PORRAS-1: Desired beam parameters for accelerator-based Boron Neutron Capture Therapy from in-phantom simulations and Nuclear Data Needs. Abstract.
| Monday
|
PORTU-1: Neutron autoradiography with Nuclear Track Detectors in Boron Neutron Capture Therapy. Abstract.
| Wednesday
|
POSTUMA-1: Design of a neutron beam for BNCT treatment of deep-seated tumours and evaluation of its therapeutic potential and suitability . Abstract.
| Monday
|
PROTTI-1: The BNCT-SPECT project at Pavia University and INFN: real time B10 dose monitoring and tomography by innovative CZT photon detectors. Abstract.
| Wednesday
|
QUAH-1: Boron Neutron Capture Therapy for Patients in Singapore – Challenges Faced and Implications for the Future. Abstract.
| Thursday
|
ROSSI-1: The BNCT at the Italian National Center for Oncological Hadrontherapy (CNAO). Abstract.
| Tuesday
|
SAKURAI-1: Treatment planning for BNCT - from the experience of the reactor-based BNCT. Abstract.
| Thursday
|
SANTA CRUZ-1: Microdosimetry and BNCT. Abstract.
| Wednesday
|
SANTA CRUZ-2: BNCT in Argentina: An Interdisciplinary Approach. Abstract.
|
Tuesday
|
SANTOS-1: AB-BNCT- Neutron Spectroscopy with MIMAC-FASTn, Active Phantom and New Epithermal Limits as a Function of Tumor Depth.
Abstract.
| |
SARDJONO-1: Optimization System Beam Shaping Assembly of Cyclotron 30 MeV for Boron Neutron Capture Therapy. Abstract.
| Monday
|
SAUERWEIN-1: In search of a standard for reporting BNCT. Abstract.
| Thursday
|
SHIN-1: First Commercialization of Cyclotron-based BNCT System “NeuCure" . Abstract. | Tuesday
|
SHU-1: Design Recommendations and Considerations of Clinical AB-BNCT Facility.
Abstract.
|
Tuesday
|
SUZUKI-1: Guidebook for BPA-BNCT: Collaboration work of Japanese Society of Neutron Capture Therapy and Japanese Society for Radiation Oncology. Abstract.
| Monday, Tuesday, Wednesday, Thursday
|
TANAKA-1: Present status of physical dosimetry of BNCT. Abstract.
| Monday
|
TANAKA-2: Present status of cyclotron-based epithermal neutron source at Kyoto University. Abstract.
| Tuesday
|
TASKAEV-1: Recent advances in the development of an accelerator based neutron source for BNCT Abstract.
| Tuesday
|
TIAN-1: Simultaneous Measurement of Boron Concentration and Dose through Dual Prompt Gamma Detection. Abstract.
| Wednesday
|
WITTIG-1: Clinical trial strategies for BNCT. Abstract.
| Thursday
|
YANAGIE-1: Boron Neutron Capture Therapy planning for recurrent hepatocellular carcinoma using Boron entrapped Water-in-Oil-in-Water emulsion. Abstract.
| Wednesday
|
YOSHIHASHI-1: Development of an Accelerator driven Neutron Source for BNCT at Nagoya University. Abstract
|
Tuesday
|
